S'abonner

Allergic rhinitis phenotypes with distinct transcriptome profiles in children: A birth cohort - 03/05/24

Doi : 10.1016/j.jaci.2023.12.024 
Youn Ho Shin, MD, PhD a, , Jeong-Hyun Kim, PhD b, , Si-hyeon Lee, PhD b, So-Yeon Lee, MD, PhD c, Yoon Mee Park, PhD b, Eum Ji Choi, MD d, Eun Young Paek, MD c, Kun-Baek Song, MD e, Min Ji Park, MD f, Sungsu Jung, MD g, Jisun Yoon, MD h, Dong In Suh, MD, PhD i, Kyung Won Kim, MD, PhD j, Kangmo Ahn, MD, PhD k, Soo-Jong Hong, MD, PhD c,
a Department of Pediatrics, The Catholic University of Korea, Yeouido St Mary’s Hospital, Seoul, Korea 
b Department of Medicine, University of Ulsan College of Medicine, Seoul, Korea 
d Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 
i Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea 
j Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea 
k Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 
c Department of Pediatrics, Gyeongsang National University Changwon Hospital, Changwon, Korea 
e Department of Pediatrics, Soonchunhyang University Cheonan Hospital, Cheonan, Korea 
f Department of Pediatrics, Hallym Sacred Heart Hospital, Anyang, Korea 
g Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea 
h Department of Pediatrics, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea 

Corresponding author: Soo-Jong Hong, MD, PhD, Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea.Department of PediatricsChildhood Asthma Atopy CenterHumidifier Disinfectant Health CenterAsan Medical CenterUniversity of Ulsan College of MedicineRepublic of Korea

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Abstract

Background

Allergic rhinitis (AR) phenotypes in childhood are unclear.

Objectives

This study sought to determine AR phenotypes and investigate their natural course and clinical and transcriptomic characteristics.

Methods

Latent class trajectory analysis was used for phenotyping AR in 1050 children from birth through 12 years using a birth cohort study. Blood transcriptome analyses were performed to define the underlying mechanisms of each phenotype.

Results

Five AR phenotypes were identified: early onset (n = 88, 8.4%), intermediate transient (n = 110, 10.5%), late onset (n = 209, 19.9%), very late onset (n=187, 17.8%), and never/infrequent (n = 456, 43.4%). Children with early-onset AR were associated with higher AR severity and sensitizations to foods at age 1 year and inhalants at age 3 years and asthma symptoms, but not with bronchial hyperresponsiveness (BHR). Children with late-onset AR phenotype associated with sensitizations to various foods at age 1 year but not from age 3 years, and to inhalants from age 7 years and with asthma with BHR. Children with very late–onset AR phenotype associated with sensitizations to foods throughout preschool age and to inhalants at ages 7 and 9 years and with asthma with BHR. Transcriptome analysis showed that early-onset AR was associated with viral/bacterial infection–related defense response, whereas late-onset AR was associated with T cell–related immune response.

Conclusions

Early-onset AR phenotype was associated with sensitization to foods and inhalants at an early age and asthma symptoms, but not with BHR, whereas very late– and late-onset AR phenotypes were positively associated with sensitization to inhalants and asthma with BHR. Transcriptomic analyses indicated that early- and late-onset AR phenotypes had distinct underlying mechanisms related to AR as well.

Le texte complet de cet article est disponible en PDF.

Key words : Allergic rhinitis, phenotype, comorbidity, trajectory, transcriptome, children

Abbreviations used : AD, AR, BHR, DEG, FA, Feno, LCTA, OAS


Plan


© 2024  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 153 - N° 5

P. 1319-1329 - mai 2024 Retour au numéro
Article précédent Article précédent
  • Aggregated eosinophils and neutrophils characterize the properties of mucus in chronic rhinosinusitis
  • Yui Miyabe, Mineyo Fukuchi, Hiroki Tomizawa, Yuka Nakamura, Mitsutoshi Jikei, Yoshinori Matsuwaki, Misaki Arima, Yasunori Konno, Yuki Moritoki, Masahide Takeda, Naoya Tanabe, Hiroshi Shima, Yusuke Shiraishi, Toyohiro Hirai, Nobuo Ohta, Junko Takahata, Atsushi Matsubara, Takechiyo Yamada, Koichiro Asano, Isao Miyairi, Rossana C.N. Melo, Peter F. Weller, Shigeharu Ueki
| Article suivant Article suivant
  • A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trials
  • Natacha Go, Simon Arsène, Igor Faddeenkov, Théo Galland, Shiny Martis B., Diane Lefaudeux, Yishu Wang, Loic Etheve, Evgueni Jacob, Claudio Monteiro, Jim Bosley, Caterina Sansone, Christian Pasquali, Lorenz Lehr, Alexander Kulesza

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.